Pharmacosmos Therapeutics
UEI: WTSLJYG8SYG5
• CAGE: 8ZVB7
Overview
Awardee Type
Parent
Federal Capability Statement
At Pharmacosmos, we are specialists in iron therapy. We develop, manufacture and market medicines for the treatment of iron deficiency anaemia in humans and animals. We are furthermore specialists in developing and producing advanced carbohydrates for pharmaceutical and technical uses.
Keywords
Iron deficiency, patient safety, recovery
Website
Headquarters
Morristown, NJ
United States
United States
Federal recipient
PHARMACOSMOS THERAPEUTICS INC
(UEI WTSLJYG8SYG5, CAGE 8ZVB7)
is headquartered in Morristown NJ.
Its primary registered NAICS is 424210 Drugs and Druggists' Sundries Merchant Wholesalers.
The corporation
was founded in September 2019 and
federally registered in
March 2021.
Federal Registration and Certifications
Legal Name
PHARMACOSMOS THERAPEUTICS INC
UEI
WTSLJYG8SYG5
CAGE Code
8ZVB7
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Sept. 1, 2019
Initial Registration
March 19, 2021
Last Registration
Dec. 2, 2024
Registration Activation
Dec. 2, 2024
Registration Expiration
Nov. 26, 2025
Fiscal Year End
April 30
Reported Entity Types
For Profit Organization
Manufacturer of Goods
Manufacturer of Goods
State of Incorporation
NJ
Country of Incorporation
USA
Employees
<500
Disaster Registry
Nationwide
Reported NAICS
Accepts Credit Cards
Yes
People
Vendor contacts at Pharmacosmos Therapeutics
GSA Schedules and Price Lists
- Pharmacosmos Therapeutics
- PoP: 9/28/21 - 9/28/26
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Pharmacosmos Therapeutics
- PoP: 6/16/21 - 9/29/21 (Ended)